نوع المستند : مقالات علمیة محکمة
المؤلفون
1 قسم علوم وتکنولوجيا الأغذية ـ کلية الزراعة ـ جامعة أسيوط
2 قسم علوم الأغذية ـ کلية التربية النوعية ـ جامعة عين شمس
3 قسم الکيمياء الحيوية ـ کلية الطب ـ جامعة أسيوط
4 قسم الاقتصاد المنزلي ـ کلية التربية النوعية ـ جامعة أسيوط
المستخلص
الموضوعات الرئيسية
Introduction
In nature many thousands of species of mushrooms are located varying in form, color, size, strength and appearance and the nature of growth, taste with very tasty flavor. Most of such types have delicious flavor, however a few percentage of them are toxic kinds such as Agaricus compestris, Pleurotus ostreatus, Lentinus Edodes, Flammulina Velutipes, Ganoderma Lucidium and Agaricus Blazei. (Hussain et al. 2006).
Edible mushrooms had been widely utilized as a human foods for centuries and had been appreciated for texture and flavor as well as some medicinal and tonic attributes (Manzi et al., 2001). However, the awarness of mushrooms as a healthy food and as an important source of biological active substances with medicinal value had only recently emerged (Cheung, 1999). Mushrooms are considered as healthy food because they are low in calories and fat but rich in proteins and dietary fibers (Manzi et al., 1999).
Kuruswa et al. (1982) reported that Mushroom effectively lowered plasma cholesterol in laboratory animals. Shahdat et al., 2003 reported that the feeding of 5% powder of the fruiting bodies of P. ostreatus mushrooms to hypercholesterolaemic rats reduced their plasma total cholesterol by approximately 28%, low density lipoprotein–cholesterol by approximately 55%, triglyceride by approximately 34%, non-esterified fatty acid by approximately 30% and total liver cholesterol levels by > 34%, with a concurrent increase in plasma high-density lipoprotein cholesterol concentration of > 21%. However, these effects were not observed in mushroom-fed normocholesterolaemic rats. Mushroom feeding significantly increased plasma fatty acid unsaturation in both normo- and hypercholesterolaemic rats and the 5% (Pleurotus ostreatus)supplementation provides health benefits, at least partially, by acting on the atherogenic lipid profile in the hypercholesterolaemic condition.
Fukushima et al., (2000) reported that (Agaricus bisporous)decreases serum low-density lipoprotein–cholesterol (LDL-C) by increasing the expression of low-density lipoprotein (LDL) receptor mRNA levels and LDL receptor activity.
Hashimoto et al., (1999) and Hashimoto et al., (2001) suggested that one of the most important food components that helped reduce serum cholesterol was its polyunsaturated fatty acid content.
Stamlo et al., (1986) mentioned that mushroom was lowering of high serum cholesterol levels and played a significant role in the prevention of atherosclerosis.
Higher fungi are an ideal dietary substance for the prevention and treatment of hypercholesterolemia due to the high content of dietary fiber, protein and microelements and the presence of plant sterols, as well as the low energy content. Lowering of circulating cholesterol especially the low density lipoprotein (LDLC) fraction can prevent arrest even reverse coronary atherosclerosis (Barter and Rye 1996).
Grundy (1986) reported thatHigh-density lipoprotein (HDL) had been called the "good" cholesterol because high levels of it reduce an individual's tendency to develop atherosclerosis. HDL protects the blood vessels by removing some of the cholesterol from the arterial walls and possibly by slowing cholesterol's entry into tissues (Mahley et al. 1978). HDL also promotes the production of prostacydin, a substance that inhibits clotting along the inner walls of arteries (Byrne 1991).
Anon (2003a) reported that diabetic patients who included 50 grams of fiber in their daily diet lowered their glucose levels by 10%. The hight-fiber diet also decreased insulin levels in the blood and lowered blood lipid concentrations in patients with type II diabetes, or non insulin dependent diabetes mellitus, the most prevalent type of diabetes.
Schaeffiner et al. (2003) stated that when the body had too much of LDL above 160 mg/dl, the LDL or "bad cholesterol" starts to accumulate along the interior walls of arteries (blood vessels supplying oxygen to the heart and brain), causing a build up or forming a plaque and even then, blood clots could also appear on the plaque restricting oxygen, blood and nutrients from getting to the heart and brain. Such a phenomenon could inevitability cause heart disease leading to heart attack or stroke.
Oyetayo (2006), reported that total body weight gain of rats fed mushroom diets were not significantly different (P > 0.05) after 28 day feeding trial, plasma total cholesterol, low density lipoprotein cholesterol and triglycerides concentrations were found to be significantly lower (P < 0.05) than control while high density lipoprotein cholesterol were significantly higher (P < 0.05) and edible mushrooms have hypocholestolemic effects and could serve an important purpose in the prevention of atherosclerosis.
Bobek et al., (1993) found that in series of experiments that long term dietary supplementation with 5% dried oyster mushroom fruiting bodies can effectively suppress dietary induced hypercholesterolemia in rats.
Pavel et al., (1997) reported that that diet supplemented with 1% oyster mushroom did not significantly affect the level of serum cholesterol or triacylglycerols and the diets supplemented with 5% oyster mushroom significantly reduced cholesterol levels, LDL, VLDL in serum in the experimental rats, while HDL was significantly higher in the serum.
El-Gengaihi et al. (2004) reported that vegetable oils markedly reduce blood cholesterol levels when substituted for animal fat in diets.
This investigation was carried out in an attempt to study the effect of the two studied mushrooms varieties on blood lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol, VLDL cholesterol and triglycerides) in the experimental albino rats.
Material and Method
Materials:
Source of Samples:
40 kg of the two mushrooms varieties namely: (Pleurotus ostreatus) and (Agaricus bisporus) were procured from Food Technology Institute (AgricultureResearchCenter) and Metro local market Giza, Cairo; respectively in March 2008.
Preparation of Samples:
The mycelia were cleaned with a minimal amount of distilled water to remove the dust and solids. The rind (outer covering) of the mycelia were removed to avoid any contamination that might come from the compost and the plastic wrapping during cultivation.
Two mushroom varieties were dried in a drying oven at 55 – 60oC for 6 – 8 hours to complete drying, thereafter were milled and kept in polyethylene bags at 5oC until required for analysis (Moharram et al., 2008).
Experimental Animals:
Fifty six adult male white albino rats (Sprague dawley strain) weighing between (100 and 120 g) provided from the animal house of the Faculty of Medicine, Assiut University were housed individually in wire cages under the normal laboratory conditions and fed on the basal diet for a week as adaptation period.
Basal diet and untreated hyperlipidemic diet:
The basal diet used is outlined in Table (1), (2) and (3)
Table (1): Constituents of the basal diet for 100 gm diet*.
|
Item |
% |
|
Corn starch |
67.8 |
|
Casein |
12.5 |
|
Corn oil |
10.0 |
|
Vitamins mixture |
1.0 |
|
Salt mixture |
3.5 |
|
Cellulose |
5.0 |
|
Choline chloride |
0.2 |
|
Total |
100.0% |
*(El-Sayed, 2001) and (Ilwy, 2003).
Table (2): Constituents of vitamins mixture used in the basal diet*.
|
Vitamins Mixture |
|
|
Item |
Amount (gm) |
|
Vitamin A plamitate 500.000 IU/gm |
0.80 |
|
Vitamin D3 100.000 IU/gm |
1.00 |
|
Vitamin E acetate 500 IU/gm |
10.00 |
|
Menadione sodium bisulfite 62.5% mendadione |
0.08 |
|
Biotin 1.0% |
2.00 |
|
Cyano cobalaming 0.01% |
1.00 |
|
Folic acid |
0.20 |
|
Nicotinic acid |
3.00 |
|
Calcium pantothenate |
1.60 |
|
Pyridoxine-Hcl |
0.70 |
|
Riboflavin |
0.60 |
|
Thiamin-Hcl |
0.60 |
|
Sucrose |
978.42 |
|
Total |
1000.00 |
* Anon (1977).
Table (3): Constituents of the salt mixture used in the basal diet*:
|
Salt Mixture |
|
|
Item |
Amount (gm) |
|
Calcium phosphate, diabase 29.5% Ca, 22.8% P |
500.00 |
|
Magnesium oxide 60.3% ug |
24.00 |
|
Potassium citrate, 1 H2O, 36.2% K |
220.00 |
|
Postassium sulfate 44.9% K, 18.4% S |
52.00 |
|
Sodium chloride 39.3% Na, 60.7% Cl |
74.00 |
|
Chromium potassium sulfate 12.0 H2O, 10.4% Cr |
0.55 |
|
Cupric carbonate 57.5% Cu |
0.30 |
|
Potassium iodate 59.3% I |
0.01 |
|
Ferric citrate 21.2% Fe |
6.00 |
|
Manganous carbonate 47.8% Mn |
3.50 |
|
Sodium selenite 45.7% Se |
0.01 |
|
Zinc carbonate 52.1 Zn |
1.60 |
|
Sucrose |
118.03 |
|
Total |
1000.00 |
* Anon (1980).
The untreated hyperlipidemic diet used is outlined in tables (2), (3) and (4).
Table (4): Constituents of the hyperlipidemic diet for 100 gm diet*.
|
Item |
% |
|
Corn starch |
66.80 |
|
Casein |
12.5 |
|
Animal fat |
10.00 |
|
Cholesterol |
1.00 |
|
Vitamins mixture |
1.00 |
|
Salt mixture |
3.50 |
|
Cellulose |
5.00 |
|
Choline chloride |
0.2 |
|
Total |
100.0% |
*(El-Sayed 2001) and (Ilwy, 2003)
Design of the experiment:
The rats were randomly allocated into (6) main groups of (6) rats each. Daily administrations were continued for two successive periods (6) weeks each. In the first period one group was used as control and was fed on basal diets, while the other five groups were fed the hyperlipidemic diet as concluded by Abd-El-Maksoud et al. (1996). In general rats were classified as following:
Group 1: Control group fed on basal diet.
Group 2: Untreated group fed on hyperlipidemic diet.
Group 3: Treated group fed on hyperlipidemic diet plus 10% dried mushroom (Agaricus bisporus).
Group 4: Treated group fed on hyperlipidemic diet plus 10% dried mushroom (Pleurotus ostreatus).
Group 5: Treated group fed on hyperlipidemic diet plus 5% dried mushroom (Agaricus bisporus).
Group 6: Treated group fed on hyperlipidemic diet plus 5% dried mushroom (Pleurotus ostreatus).
Blood sampling:
At the end of each experiment, rats were fasted overnight and anesthetized.
Blood samples were collected from the retro-orbital plexus from all animals of each group into clean, dry and labeled tube. The tubes contained heparin (10.0 IU / ml) as anticoagulant. Blood was centrifuged (3500 r-p. m for 15 min) to separate plasma which was tightly kept in sealed aliquot tubes at - 20oC until biochemical assays according to Ilwy (2003).
Methods
Biochemical methods:
Prepared samples (as mentioned in 2.1.6) were used to study the following biochemical parameters using PHOTO Mech 301-D+ spectrophotometer (Optima).
Determination of serum triglycerides:
Fully enzymatic determination of total triglycerides in serum was estimated spectrophtometrically at 500 according to the method of Wahlefeld (1974).
Determination of serum total cholesterol:
Enzymatic determination of cholesterol was carried out according to the method of Allian et al. (1974) using kits purchased from Stanbio (Texas, USA).
Determination of High Density Lipoprotein (HDL) cholesterol:
The kits were provided from Stanbio, Lab., Inc. Texas. According to Warnick et al. (1983).
Low Density Lipoprotein (LDL) cholesterol calculation:
LDL was calculated by the difference between total cholesterol, HDL cholesterol and triglyceride, according to Friedewald et al. (1972).
Determination of serum glucose:
Serum glucose level was analyzed by calorimetric procedures kits developed by Diamond diagnostics kits Cairo, Egypt using 550 according to Trinder (1969).
Statistical analysis:
Data was analyzed with applying of variance (ANOVA) procedures by using the MSTAT-C Statistical software package (Russell 1983). Where the F-test showed significant differences among means Duncan (1955) performed at the 0.05 level of probability to separate means.
Results and discussion
Serum triglycerides in the two studied mushroom varieties:
The results given in table (5) revealed that the blood serum triglycerides of the experimental animals showed significant differences among all the six studied groups at (P < 0.05).
However, the data regarding the blood serum triglycerides were (243.1±3.89 mg / dl) for group (2) of experimental rats (untreated group fed on hyperlipidemic diet).
Likewise, the blood serum triglycerides decreased significantly at (P < 0.05) recording (177.2±4.61 mg / dl) for group (3) of rat (treated group fed on hyperlipidemic diet plus 10% Agaricus bispours / rat), (194.1±3.74 mg / dl) for group (4) of rat (treated group fed on hyperlipidemic deit plus 10% Pleurotus ostreatus / rat), (211.1±3.06 mg / dl) for group (5) of rat (treated group fed on hyperlipidemic diet plus 5% Agaricus busporus / rat) and (228.0±3.05 mg / dl) for group (6) of rat (treated group fed on hperlipidemic diet plus 5% Pleurotus ostreatus / rat); respectively.
The data given in table (5) revealed that the mean values among all six studied treatments recorded significant decrease starting from 193.0 and reaching 183.2 by the end of the feeding experiment.
The present data given in table (5) on blood serum triglycerides in the serum of the experimental animals was agreed with Oyetayo (2006) who found that, rats fed mushroom diets were significantly lower triglycerides concentrations (P < 0.05).
Table (5): Effect of the six studied groups on the serum triglycerides content (mg / dl) of the experimental rats.
|
Time of observation |
Control |
Hyperlipidemic diet |
10% Agaricus bisporus |
10% Pleurotus ostreatus |
5% Agaricus bisporus |
5% Pleurotus ostreatus |
Mean |
|
Group 1 |
Group 2 |
Group 3 |
Group 4 |
Group 5 |
Group 6 |
||
|
End of 1st week ± S. E. |
132.1s ± 4.02 |
208.6hij ± 0.81 |
190.4lm ± 3.41 |
199.1jkl ± 2.51 |
207.8ij ± 2.66 |
220.0fg ± 2.21 |
193.0D ± 5.43 |
|
End of 2nd week ± S. E. |
137.2rs ± 3.93 |
227.4ef ± 1.31 |
200.0jk ± 2.90 |
214.8ghi ± 1.87 |
229.6e ± 1.15 |
242.9cd ± 3.18 |
208.6B ± 6.50 |
|
End of 3rd week ± S. E. |
141.3qrs ± 6.14 |
250.0c ± 2.66 |
203.2j ± 2.82 |
217.7gh ± 1.75 |
232.2e ± 1.77 |
247.0c ± 2.10 |
215.2A ± 6.94 |
|
End of 4th week ± S. E. |
144.0qr ± 4.86 |
258.8b ± 2.90 |
175.8n ± 5.06 |
192.4klm ± 3.64 |
209.0hij ± 2.72 |
235.8de ± 1.69 |
202.6C ± 7.15 |
|
End of 5th week ± S. E. |
148.2pq ± 5.30 |
267.6a ± 1.37 |
155.4op ± 4.60 |
177.7n ± 3.54 |
200.0jk ± 2.66 |
218.8fg ± 2.67 |
194.6D ± 7.67 |
|
End of 6th week ± S. E. |
160.8o ± 4.02 |
246.1c ± 7.29 |
138.2rs ± 2.97 |
163.0o ± 2.64 |
187.8m ± 3.73 |
203.4j ± 5.04 |
183.2E ± 6.70 |
|
Mean |
143.9E ± 2.45 |
243.1A ± 3.89 |
177.2E ± 4.61 |
194.1D ± 3.74 |
211.1C ± 3.06 |
228.0B ± 3.05 |
|
S. E. = Standard Error
Values followed by the same letter within the same column were not significantly different (P < 0.05).
F. Test (A) (week) = 86.96** F. Test (B) (Tre.) = 836.67**
F. Test (AB) = 31.47**
Serum total cholesterol in the two studied mushroom varieties:
The results given in table (6) revealed that the serum total cholesterol values significant differences among all the six studied groups at (P < 0.05) in experimental period.
However, the data regarding the blood serum total cholesterol were (283.7±9.38 mg / dl) for group (2) of experimental rats (untreated group fed on hyperlipidemic diet).
Meanwhile, the blood serum total cholesterol in groups (3, 4, 5 and 6) decreased significantly at (P < 0.05) recording (193.5±3.02 mg / dl, 204.5±2.99 mg / dl, 221.7±3.00 mg / dl and 228.4±3.19 mg / dl); respectively for these four groups of rats (treated group fed on hyperlipidemic diet plus 10% Agaricus bisporus, treated group fed on hyperlimpidemic diet plus 10% Pleurotus ostrreats, treated group fed on hyperlipidemic diet plus 5% Agaricus bisporus and treated group fed on hyperlipidemic diet plus 5% Pleurotus ostrreats / rats); respectively.
The data given in table (6) revealed that the mean values among all six studied treatments recorded significant decrease starting from 201.2 and reaching 202.8 by the end of the feeding experiment.
The present results given in table (6) were agreed with Stamlo et al., (1986) who found mushroom was lowering of high serum cholesterol levels and played a significant role in the prevention of atherosclerosis.
Table (6): Effect of the six studied groups on the serum cholesterol content (mg / dl) of the experimental rats.
|
Time of observation |
Control |
Hyperlipidemic diet |
10% Agaricus bisporus |
10% Pleurotus ostreatus |
5% Agaricus bisporus |
5% Pleurotus ostreatus |
Mean |
|
Group 1 |
Group 2 |
Group 3 |
Group 4 |
Group 5 |
Group 6 |
||
|
End of 1st week ± S. E. |
95.4s ± 2.64 |
223.2hi ± 0.82 |
207.9k ± 2.54 |
217.0ij ± 2.55 |
227.6fgh ± 2.84 |
236.2def ± 6.12 |
201.2C ± 9.02 |
|
End of 2nd week ± S. E. |
104.2r ± 3.06 |
233.0efg ± 0.95 |
208.6jk ± 2.60 |
219.4hi ± 2.52 |
234.6efg ± 3.70 |
243.8cd ± 2.42 |
207.3B ± 8.87 |
|
End of 3rd week ± S. E. |
113.6q ± 3.43 |
248.4c ± 1.52 |
209.2jk ± 2.52 |
221.0hi ± 2.45 |
237.2de ± 2.63 |
240.6cde ± 2.18 |
211.7A ± 8.54 |
|
End of 4th week ± S. E. |
117.4q ± 2.16 |
322.9b ± 5.58 |
185.8mn ± 2.29 |
198.8l ± 2.44 |
226.4gh ± 2.11 |
232.8efg ± 2.08 |
214.0A ± 11.48 |
|
End of 5th week ± S. E. |
120.1q ± 2.20 |
325.0b ± 4.64 |
177.2op ± 2.13 |
189.0mn ± 1.76 |
210.8jk ± 3.18 |
219.0hi ± 3.91 |
206.9B ± 11.52 |
|
End of 6th week ± S. E. |
121.4q ± 3.33 |
349.7a ± 2.32 |
172.2p ± 1.02 |
181.8no ± 0.92 |
193.8lm ± 2.82 |
197.8l ± 1.24 |
202.8C ± 13.09 |
|
Mean |
112.0F ± 2.03 |
283.7A ± 9.38 |
193.5E ± 3.02 |
204.5D ± 2.99 |
221.7C ± 3.00 |
228.4B ± 3.19 |
|
S. E. = Standard Error
Values followed by the same letter within the same column were not significantly different (P < 0.05).
F. Test (A) (week) = 18.88** F. Test (B) (Tre.) = 2444.19**
F. Test (AB) = 106.54**
Serum HDL (High Density Lipoprotein) in the two studied mushroom varieties:
The results given in table (7) revealed that the serum HDL of the experimental animals showed significant differences among all the six studied groups at (P < 0.05) in experimental period.
However, the data showed significant differences between group (1) (control group fed on basal diet) recording (52.61±1.11 mg / dl) and all other groups in the two studied mushroom varieties namely: (Agaricus bisporus) and (Pleurotus ostrreats).
On the other hand, significant differences between group (2) (untreated group fed on hyperlipidemic diet) recording (53.07±0.77 mg / dl) and groups (3, 4, 5 and 6) were recorded.
However, the serum HDL cholesterol in group (3) (treated group fed on hyperlipidemic diet plus 10% Agaricus bisporus / rat) recorded increased significantly at (P < 0.05) recording (81.22±3.08 mg / dl).
But, the serum HDL cholesterol in groups (4, 5 and 6) (treated group fed on hyperlipidemic diet plus 10% Pleurotus ostreatus, treated group fed on hyperlipidiemic diet plus 5% Agaricus bisporus and treated group fed on hyperlipidemic diet plus 5% Pleurotus ostreatus / rats) recorded (76.86±2.51 mg / dl, 72.60±2.14 mg / dl and 66.07±1.62 mg / dl); respectively.
The data given in table (7) revealed that the mean values among all six studied treatments recorded significant increase starting from 58. 52 and reaching 77.75 by the end of the feeding experiment.
The present results given in table (7) were agreed with. Oyetayo (2006) who found high density lipoprotein cholesterol were significantly higher (P < 0.05) when rats fed on mushroom diets.
Table (7): Effect of the six studied groups on the serum HDL content (mg / dl) of the experimental rats.
|
Time of observation |
Control |
Hyperlipidemic diet |
10% Agaricus bisporus |
10% Pleurotus ostreatus |
5% Agaricus bisporus |
5% Pleurotus ostreatus |
Mean |
|
Group 1 |
Group 2 |
Group 3 |
Group 4 |
Group 5 |
Group 6 |
||
|
End of 1st week ± S. E. |
51.12qrs ± 1.94 |
52.00pqr ± 2.61 |
67.48hij ± 5.07 |
63.31ijkl ± 2.92 |
59.20klmno ± 2.73 |
58.01lmnopq ± 2.55 |
58.52E ± 1.58 |
|
End of 2nd week ± S. E. |
56.40lmnopqr ± 1.69 |
52.40opqr ± 2.52 |
58.52klmnop ± 3.27 |
59.87klmn ± 2.16 |
61.80jklm ± 1.28 |
55.40mnopqr ± 1.72 |
57.40E ± 1.00 |
|
End of 3rd week ± S. E. |
59.40klmno ± 2.56 |
54.80mnopqr ± 1.98 |
78.94fg ± 2.22 |
73.27gh ± 1.25 |
67.60hij ± 1.50 |
65.20ijk ± 2.48 |
66.54D ± 1.68 |
|
End of 4th week ± S. E. |
53.00nopqr ± 1.05 |
54.40nopqr ± 0.68 |
85.46de ± 3.17 |
80.71ef ± 1.46 |
76.00fg ± 1.76 |
69.00hi ± 2.77 |
69.76C ± 2.42 |
|
End of 5th week ± S. E. |
45.20s ± 2.84 |
55.20mnopqr ± 0.80 |
93.22bc ± 2.10 |
87.11cde ± 1.07 |
81.00ef ± 2.07 |
73.00gh ± 1.87 |
72.46B ± 3.26 |
|
End of 6th week ± S. E. |
50.56rs ± 0.58 |
49.60rs ± 1.44 |
103.70a ± 3.47 |
96.86b ± 2.09 |
90.00cd ± 2.17 |
75.80fg ± 2.13 |
77.75A ± 4.04 |
|
Mean |
52.61E ± 1.11 |
53.07E ± 0.77 |
81.22A ± 3.08 |
76.86D ± 2.51 |
72.60C ± 2.14 |
66.07D ± 1.62 |
|
S. E. = Standard Error
Values followed by the same letter within the same column were not significantly different (P < 0.05).
F. Test (A) (week) = 84.15** F. Test (B) (Tre.) = 194.31**
F. Test (AB) = 14.67**
Serum LDL (Low Density Lipoprotein) in the two studied mushroom varieties:
The results given in table (8) revealed that the serum LDL showed significant differences among all the six studied groups, all feeding weeks at (P < 0.05) in experimental period.
Meanwhile, the data regarding the serum LDL cholesterol were (182.1± 8.95 mg / dl) for group (2) of experimental rats (untreated group fed on hyperlipidemic diet).
On the other hand, the serum LDL cholesterol in groups (3, 4, 5 and 6) decreased significantly at (P < 0.05) recording (76.8±4.97 mg / dl, 88.6±4.57 mg / dl, 106.9±4.36 mg / dl and 116.2±3.80 mg / dl); respectively for two groups of mushroom varieties.
The data given in table (8) revealed that the mean values among all six studied treatments recorded significant decrease starting from 103.4 and reaching 88.3 by the end of the feeding experiment.
The present results given in table (8) were agreed with Shahdat et al., (2003) who found Mushroom feeding significantly increased plasma fatty acid unsaturation in both normo- and hypercholesterolaemic rats and the 5% (Pleurotus ostreatus)supplementation provided health benefits, at least partially, by acting on the atherogenic lipid profile in the hypercholesterolaemic condition.
On the other hand, Barter and Rye (1996) found that, lowering of circulating cholesterol especially the low density lipoprotein (LDL) cholesterol fraction could prevent arrest or even reverse coronary atherosclerosis.
Table (8): Effect of the six studied groups on the serum LDL content (mg / dl) of the experimental rats.
|
Time of observation |
Control |
Hyperlipidemic diet |
10% Agaricus bisporus |
10% Pleurotus ostreatus |
5% Agaricus bisporus |
5% Pleurotus ostreatus |
Mean |
|
Group 1 |
Group 2 |
Group 3 |
Group 4 |
Group 5 |
Group 6 |
||
|
End of 1st week ± S. E. |
17.9q ± 3.19 |
129.5ef ± 2.36 |
102.4k ± 4.40 |
113.9hij ± 1.07 |
126.8efg ± 2.30 |
130.2def ± 1.88 |
103.4B ± 7.41 |
|
End of 2nd week ± S. E. |
20.4q ± 3.82 |
135.1cde ± 2.22 |
110.1ijk ± 2.70 |
115.0hi ± 2.09 |
126.9efg ± 3.50 |
139.8cd ± 3.00 |
107.9A ± 7.60 |
|
End of 3rd week ± S. E. |
25.6q ± 4.43 |
143.8c ± 2.38 |
89.6l ± 3.71 |
104.2jk ± 3.09 |
123.2fgh ± 3.35 |
126.8efg ± 3.05 |
102.2B ± 7.23 |
|
End of 4th week ± S. E. |
35.6p ± 2.80 |
216.7b ± 5.57 |
65.2n ± 4.62 |
79.6m ± 3.41 |
108.6ijk ± 2.22 |
116.6ghi ± 4.27 |
103.7B ± 10.73 |
|
End of 5th week ± S. E. |
45.3op ± 4.68 |
216.3b ± 4.56 |
52.9o ± 3.79 |
66.4n ± 3.10 |
89.8l ± 4.06 |
102.2k ± 4.03 |
95.5C ± 10.79 |
|
End of 6th week ± S. E. |
38.7p ± 3.88 |
250.9a ± 5.19 |
40.5p ± 3.02 |
52.4o ± 2.47 |
66.2n ± 5.00 |
81.3lm ± 1.98 |
88.3D ± 13.85 |
|
Mean |
30.6F ± 2.34 |
182.1A ± 8.95 |
76.8E ± 4.97 |
88.6D ± 4.57 |
106.9C ± 4.36 |
116.2B ± 3.80 |
|
S. E. = Standard Error
Values followed by the same letter within the same column were not significantly different (P < 0.05).
F. Test (A) (week) = 26.93** F. Test (B) (Tre.) = 1356.96**
F. Test (AB) = 91.54**
Serum VLDL cholesterol in the two studied mushroom varieties:
The results given in table (9) revealed that the serum VLDL cholesterol showed significant differences among all studied groups at (P < 0.05) in experimental period.
However, the data regarding the blood serum VLDL-cholesterol were (48.59±0.78 mg / dl) for group (2) of experimental rats (untreated group fed on hyperlipidemic diet).
Likewise, the serum VLDL-cholesterol decreased significantly at (P < 0.05) for groups (3, 4, 5 and 6) of experimental rats to recording (35.43±0.92 mg / dl) for group (3) of experimental rats (treated group fed on hyperlipidemic diet plus 10% Agaricus bisporus / rat), (38.76±0.74 mg / dl) for group (4) of rat (treated group fed on hyperlimpidemic diet plus 10% Pleurotus ostrreats / rat), (42.22±0.61 mg / dl) for group (5) of rat (treated group fed on hyperlipidemic diet plus 5% Agaricus bisporus / rat) and (45.46±0.60 mg / dl) for group (6) of rat (treated group fed on hyperlipidemic diet plus 5% Pleurotus ostrreats / rat); respectively.
The data given in table (9) revealed that the mean values among all six studied treatments recorded significant decrease starting from 38.60 and reaching 36.64 by the end of the feeding experiment.
The present results given in table (9) were agreed with Pavel et al., (1997) who found that, dose 5% of Oyster mushroom reduced cholesterol content very low density lipoproteins and VLDL.
Table (9): Effect of the six studied groups on the serum VLDL content (mg / dl) of the experimental rats.
|
Time of observation |
Control |
Hyperlipidemic diet |
10% Agaricus bisporus |
10% Pleurotus ostreatus |
5% Agaricus bisporus |
5% Pleurotus ostreatus |
Mean |
|
Group 1 |
Group 2 |
Group 3 |
Group 4 |
Group 5 |
Group 6 |
||
|
End of 1st week ± S. E. |
26.42q ± 0.80 |
41.72ghi ± 0.16 |
38.08jk ± 0.68 |
39.82ij ± 0.52 |
41.57ghi ± 0.53 |
44.00ef ± 0.44 |
38.60D ± 1.09 |
|
End of 2nd week ± S. E. |
27.44pq ± 0.78 |
45.47de ± 0.26 |
40.00ij ± 0.58 |
42.58fgh ± 0.57 |
45.92d ± 0.23 |
48.58bc ± 0.64 |
41.67B ± 1.30 |
|
End of 3rd week ± S. E. |
28.24opq ± 1.22 |
49.86b ± 0.61 |
40.64hi ± 0.56 |
43.54fg ± 0.35 |
46.44d ± 0.35 |
48.60bc ± 0.99 |
42.89A ± 1.37 |
|
End of 4th week ± S. E. |
28.78op ± 0.97 |
51.78a ± 0.58 |
35.16l ± 1.01 |
38.48jk ± 0.73 |
41.80ghi ± 0.54 |
47.16cd ± 0.34 |
40.53C ± 1.43 |
|
End of 5th week ± S. E. |
29.64no ± 1.06 |
53.50a ± 0.28 |
31.08mn ± 0.92 |
35.54l ± 0.71 |
40.00ij ± 0.53 |
43.76ef ± 0.53 |
38.92D ± 1.53 |
|
End of 6th week ± S. E. |
32.16m ± 0.80 |
49.18b ± 1.47 |
27.64pq ± 0.59 |
32.60m ± 0.53 |
37.56k ± 0.75 |
40.68hi ± 1.01 |
36.64E ± 1.34 |
|
Mean |
28.781F ± 0.49 |
48.59A ± 0.78 |
35.43E ± 0.92 |
38.76D ± 0.74 |
42.22C ± 0.61 |
45.46B ± 0.60 |
|
S. E. = Standard Error
Values followed by the same letter within the same column were not significantly different (P < 0.05).
F. Test (A) (week) = 76.89** F. Test (B) (Tre.) = 797.15**
F. Test (AB) = 28.84**
Serum glucose in the two studied mushroom varieties:
The results given in table (10) revealed that the serum glucose showed significant differences among all the six studied groups, all feeding weeks as well as interaction studied groups and feeding weeks at (P < 0.05) in experimental period.
However, the data regarding the serum glucose were (130.8± 4.17 mg / dl) for group (2) of experimental rats (untreated group fed on hyperlipidemic diet).
Likewise, the serum glucose decreased significantly at (P < 0.05) for groups (3, 4, 5 and 6) of experimental rats to recording (106.8 ± 1.98 mg / dl) for group (3) of experimental rats (treated group fed on hyperlipidemic diet plus 10% Agaricus bisporus / rat), (113.3±2.08 mg / dl) for group (4) of rat (treated group fed on hyperlimpidemic diet plus 10% Pleurotus ostrreats / rat), (119.8±2.37 mg / dl) for group (5) of rat (treated group fed on hyperlipidemic diet plus 5% Agaricus bisporus / rat) and (122.4±2.47 mg / dl) for group (6) of rat (treated group fed on hyperlipidemic diet plus 5% Pleurotus ostrreats / rat); respectively.
The data given in table (10) revealed that the mean values among all six studied treatments recorded significant increase starting from 91.8 and reaching 120.7 by the end of the feeding experiment.
Table (10): Effect of the six studied groups on the serum glucose content (mg / dl) of the experimental rats.
|
Time of observation |
Control |
Hyperlipidemic diet |
10% Agaricus bisporus |
10% Pleurotus ostreatus |
5% Agaricus bisporus |
5% Pleurotus ostreatus |
Mean |
|
Group 1 |
Group 2 |
Group 3 |
Group 4 |
Group 5 |
Group 6 |
||
|
End of 1st week ± S. E. |
90.8op ± 2.19 |
90.8op ± 1.77 |
87.6p ± 1.24 |
91.4nop ± 1.40 |
95.3mno ± 1.79 |
95.1mno ± 2.62 |
91.8C ± 0.86 |
|
End of 2nd week ± S. E. |
98.1lm ± 5.28 |
119.4fg ± 0.92 |
111.1ij ± 2.81 |
113.6ghij ± 2.98 |
116.1fghi ± 3.37 |
122.4ef ± 2.34 |
113.5B ± 1.88 |
|
End of 3rd week ± S. E. |
97.2lmn ± 0.64 |
129.1d ± 3.17 |
120.6ef ± 1.17 |
125.6de ± 1.74 |
130.6d ± 2.88 |
131.6d ± 3.07 |
122.5A ± 2.37 |
|
End of 4th week ± S. E. |
101.7l ± 2.70 |
139.0c ± 2.67 |
108.6jk ± 2.58 |
118.7fgh ± 1.06 |
128.7d ± 1.19 |
130.0d ± 1.46 |
121.1A ± 2.51 |
|
End of 5th week ± S. E. |
97.9lm ± 1.84 |
148.3b ± 2.58 |
109.7j ± 1.29 |
117.7fgh ± 0.94 |
125.7de ± 1.72 |
129.0d ± 1.40 |
121.4A ± 3.01 |
|
End of 6th week ± S. E. |
101.4l ± 2.49 |
158.3a ± 3.70 |
103.1kl ± 1.21 |
112.8hij ± 1.40 |
122.4ef ± 2.01 |
126.2de ± 1.46 |
120.7A ± 3.64 |
|
Mean |
97.9F ± 1.26 |
130.8A ± 4.17 |
106.8E ± 1.98 |
113.3D ± 2.08 |
119.8C ± 2.37 |
122.4B ± 2.47 |
|
S. E. = Standard Error
Values followed by the same letter within the same column were not significantly different (P < 0.05).
F. Test (A) (week) = 214.87** F. Test (B) (Tre.) = 210.79**
F. Test (AB) = 18.19**
In conclusion, on the basis of above mentioned data, there were significant differences between untreated group and all other (5) studied groups of the experimental rats (P < 0.05) in the serum triglycerides, total cholesterol, HDL cholesterol, LDL cholesterol, VLDL cholesterol and serum glucose levels, while group (3) (treated group fed on hyperlipidemic diet plus 10% Agaricus bisporus) recorded the lowest mean.
)
مشاهدة على SCiNiTO